title: [Tumor markers used in the diagnosis, monitoring, treatment, and prognosis head and neck cancer].
abstract: Cancer is currently the second to heart disease and vascular cause of death and observed tends to increase the number of cases. The cause of high mortality from cancer it is too late malignant diagnosis. In the case of head and neck cancers at diagnosis in about 40% of patients found to have metastatic lymph nodes within. Therefore, an important issue for modem oncology is the early diagnosis of the disease cancer. Currently high hopes for the early detection and diagnosis of treatmen cancer is put in simple, accessible and low-cost testing to determine the biochemical tumor markers. THE AIM OF THE STUDY was to examine the latest reports on biochemical markers useful in cancer diagnosis, disease staging, prognosis and monitoring the treatment of the most common cancers of the head and neck.
  
  
  METHODS
  The material consisted of references of the last 17 years. Criterion search accounted for password: biochemical tumor markers, diagnostics, monitoring treatment of cancer. 10 of 90 works were selected to examine.
  
  
  CONCLUSIONS
  Usefulness of biochemical tumor markers in monitoring course of the disease and evaluation of treatment effectiveness was demonstrated. In combination with other diagnostic methods as they apply to screening, as well as in the detection of cancer in the study population.
authors.affiliation: Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Pracownia Miniimplantów Ortodontycznych Katedry i Kliniki Ortopedii Szczekowej i Ortodoncji. pkopczynski@orto1.net
authors.forename: Przemysław
authors.initials: P
authors.lastname: Kopczyński
authors.forename: Rafał
authors.initials: R
authors.lastname: Flieger
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis* / Q000145:classification*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D042241:Early Diagnosis; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D008207:Lymphatic Metastasis; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen